CN102091177A - Traditional Chinese medicine health product for adjuvant therapy of diabetes - Google Patents
Traditional Chinese medicine health product for adjuvant therapy of diabetes Download PDFInfo
- Publication number
- CN102091177A CN102091177A CN2011100628125A CN201110062812A CN102091177A CN 102091177 A CN102091177 A CN 102091177A CN 2011100628125 A CN2011100628125 A CN 2011100628125A CN 201110062812 A CN201110062812 A CN 201110062812A CN 102091177 A CN102091177 A CN 102091177A
- Authority
- CN
- China
- Prior art keywords
- radix
- chinese medicine
- adjuvant therapy
- diabetes
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for adjuvant therapy of diabetes, belonging to the field of traditional Chinese medicine health products. The traditional Chinese medicine composition for adjuvant therapy of diabetes comprises the following raw materials in weight to be prepared into active components: 10-50g of astragali radix, 10-50g of radix rehmanniae, 5-30g of atractylodes rhizome, 10-50g of radix scrophulariae, 10-50g of red sage root and 10-50g of kudzu root. The traditional Chinese medicine composition is prepared by the following steps: removing impurities from the crude medicines, putting all the crude medicines into a marmite, adding 1000mm of water, soaking for 1 hour, decocting for 1 hour twice and adding 1000mm of water each time, filtering, combining the filtrates, concentrating the filtrate by pressure reduction to form an extract, and filling into bottles or bags. The liquid medicine also can be dried by vacuum drying and crushed to be used as a raw material to be prepared in various dosage forms such as tablets, capsules, powder and the like. One dose of the traditional Chinese medicine composition is taken in twice per day. The medicament provided by the invention wholly adopts natural Chinese herbal medicines and has a reasonable prescription and obvious curative effects on adjuvant therapy of diabetes without toxic side effects, and the components are simple and easy to obtain and have synergistic actions.
Description
Technical field
The present invention relates to a kind of Chinese medicine health care product, specifically a kind of Chinese medicine health care product that diabetes is had the auxiliary treatment effect.
Technical background
Diabetes are the chronic metabolic diseases of a kind of whole body, the disease of serious harm human health, and global diabetics surpasses 300,000,000.In China, along with the change of expanding economy and people's dietary structure, and the aging of population, the quantity of diabetics sharply increases, and occupies first place in the world.Diabetic duration is long, easily brings out multiple acute and chronic complication again, has brought huge threat for patient's physical and mental health.The current diabetes of conventional therapy clinically all are based on Western medicine, as biguanides, sulphanylureas etc., these medicines can only be simple blood sugar lowering, the function of the organ-tissue that but can not effective for repairing impaired islet tissue and recovering has come to harm, even more serious is body also will cause hepatic and renal function in the process of these hypoglycemic medicines of metabolism side effect such as infringement, so can not take medicine for a long time.
Summary of the invention
The purpose of this invention is to provide and a kind of diabetes are had the Chinese medicine health care product of auxiliary treatment effect, the composition of this Chinese medicine health care product is natural Chinese herbal medicines, and prescription rationally can be taken for a long time, has no side effect.
Purpose of the present invention is achieved by the following technical programs.
1, a kind of Chinese medicine composition of adjuvant therapy of diabetes is characterized in that it being formulated by Radix Astragali, the Radix Rehmanniae, Rhizoma Atractylodis, Radix Scrophulariae, Radix Salviae Miltiorrhizae, Radix Puerariae.
2, the Chinese medicine composition of adjuvant therapy of diabetes according to claim 1 is characterized in that the formulation by weight of each component is:
Radix Astragali 10-50g Radix Rehmanniae 10-50g Rhizoma Atractylodis 5-30g
Radix Scrophulariae 10-50g Radix Salviae Miltiorrhizae 10-50g Radix Puerariae 10-50g.
3, the Chinese medicine composition of adjuvant therapy of diabetes according to claim 1 is characterized in that the formulation by weight of each component is optimized for:
Radix Astragali 30g Radix Rehmanniae 30g Rhizoma Atractylodis 15g
Radix Scrophulariae 30g Radix Salviae Miltiorrhizae 30g Radix Puerariae 15g.
4, the Chinese medicine composition of adjuvant therapy of diabetes according to claim 1 is characterized in that each component in marmite, adds 1000 milliliters in water, soaked 1 hour, and decocted 2 times, add 1000 milliliters in water at every turn, decocted 1 hour, and filtered, merge medicinal liquid, filtrate decompression is condensed into clear paste, fill becomes bottle or bag promptly to get oral liquid, also can pulverize with the medicinal liquid vacuum drying to doing, as raw material for standby, can be made into various dosage forms such as tablet, capsule, powder.Potion consumption on the one is taken at twice.
Pharmacological action:
Radix Astragali: can mend the gas of the whole body, have yang invigorating concurrently, strengthening superficial resistance to stop perspiration, evacuation of pus granulation promoting, inducing diuresis to remove edema, the effect of antiabortive beneficial blood.
The Radix Rehmanniae: clearing away heat and cooling blood, tonifying YIN promote the production of body fluid.
Rhizoma Atractylodis: drying damp and strengthening spleen, expelling wind and cold makes eye bright.
Radix Scrophulariae: clearing away heat and cooling blood, YIN nourishing and the production of body fluid promoting, eliminating fire and detoxication, hard masses softening and resolving.
Radix Salviae Miltiorrhizae: promoting blood flow to regulate menstruation, stasis-dispelling and pain-killing, removing heat from blood eliminating carbuncle, the relieving restlessness that clears away heart-fire, nourishing blood to tranquillize the mind.
Radix Puerariae: induce sweat and bring down a fever, promote the production of body fluid, rash, yang invigorating antidiarrheal.
The present invention with above-mentioned Chinese medicine composition after, drug effect has synergism, but adjuvant therapy of diabetes can take for a long time, effect is remarkable, has no side effect.
The specific embodiment
Embodiment 1: the Chinese medicine composition of this kind adjuvant therapy of diabetes, and the formulation by weight of each component is:
Radix Astragali 30g Radix Rehmanniae 30g Rhizoma Atractylodis 15g
Radix Scrophulariae 30g Radix Salviae Miltiorrhizae 30g Radix Puerariae 15g.
Receive all medicines in marmite, add 1000 milliliters in water, soaked 1 hour, decoct 2 times, add 1000 milliliters in water at every turn, decocted 1 hour, filter, merge medicinal liquid.Filtrate decompression is condensed into clear paste, and fill becomes bottle or bag.Potion on the one is taken at twice.
Embodiment 2: the Chinese medicine composition of this kind adjuvant therapy of diabetes, and the formulation by weight of each component is:
Radix Astragali 30g Radix Rehmanniae 30g Rhizoma Atractylodis 15g
Radix Scrophulariae 30g Radix Salviae Miltiorrhizae 30g Radix Puerariae 15g.
Receive all medicines in marmite, add 1000 milliliters in water, soaked 1 hour, decoct 2 times, add 1000 milliliters in water at every turn, decocted 1 hour, filter, merge medicinal liquid.The medicinal liquid vacuum drying is pulverized to doing, and makes powder.Potion on the one is taken at twice.
Embodiment 3: the Chinese medicine composition of this kind adjuvant therapy of diabetes, and the formulation by weight of each component is:
Radix Astragali 30g Radix Rehmanniae 30g Rhizoma Atractylodis 15g
Radix Scrophulariae 30g Radix Salviae Miltiorrhizae 30g Radix Puerariae 15g.
Receive all medicines in marmite, add 1000 milliliters in water, soaked 1 hour, decoct 2 times, add 1000 milliliters in water at every turn, decocted 1 hour, filter, merge medicinal liquid.The medicinal liquid vacuum drying is pulverized to doing, and is encapsulated.Potion on the one is taken at twice.
Claims (4)
1. the Chinese medicine composition of an adjuvant therapy of diabetes is characterized in that it being formulated by Radix Astragali, the Radix Rehmanniae, Rhizoma Atractylodis, Radix Scrophulariae, Radix Salviae Miltiorrhizae, Radix Puerariae.
2. the Chinese medicine composition of adjuvant therapy of diabetes according to claim 1 is characterized in that the formulation by weight of each component is:
Radix Astragali 10-50g Radix Rehmanniae 10-50g Rhizoma Atractylodis 5-30g
Radix Scrophulariae 10-50g Radix Salviae Miltiorrhizae 10-50g Radix Puerariae 10-50g.
3. the Chinese medicine composition of adjuvant therapy of diabetes according to claim 1 is characterized in that the formulation by weight of each component is optimized for:
Radix Astragali 30g Radix Rehmanniae 30g Rhizoma Atractylodis 15g
Radix Scrophulariae 30g Radix Salviae Miltiorrhizae 30g Radix Puerariae 15g.
4. the Chinese medicine composition of adjuvant therapy of diabetes according to claim 1 is characterized in that each component in marmite, adds 1000 milliliters in water, soaked 1 hour, and decocted 2 times, add 1000 milliliters in water at every turn, decocted 1 hour, and filtered, merge medicinal liquid, filtrate decompression is condensed into clear paste, fill becomes bottle or bag promptly to get oral liquid, also can pulverize with the medicinal liquid vacuum drying to doing, as raw material for standby, can be made into various dosage forms such as tablet, capsule, powder.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011100628125A CN102091177A (en) | 2011-03-16 | 2011-03-16 | Traditional Chinese medicine health product for adjuvant therapy of diabetes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011100628125A CN102091177A (en) | 2011-03-16 | 2011-03-16 | Traditional Chinese medicine health product for adjuvant therapy of diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102091177A true CN102091177A (en) | 2011-06-15 |
Family
ID=44124555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011100628125A Pending CN102091177A (en) | 2011-03-16 | 2011-03-16 | Traditional Chinese medicine health product for adjuvant therapy of diabetes |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102091177A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102526332A (en) * | 2012-02-07 | 2012-07-04 | 广西圣特药业有限公司 | Medicine for treating diabetes and preparation method thereof |
| CN103083461A (en) * | 2012-12-06 | 2013-05-08 | 宁夏易欣回药科技有限公司 | Medicine composition for treating diabetes |
| CN103989988A (en) * | 2014-04-22 | 2014-08-20 | 安徽省太湖山中药饮片有限公司 | Traditional Chinese medicine composition for assisting diabetes treatment |
| CN107582859A (en) * | 2017-10-25 | 2018-01-16 | 陆惠红 | A kind of Chinese medicine for treating diabetes |
| CN108096468A (en) * | 2017-12-15 | 2018-06-01 | 佛山市米良仓科技有限公司 | A kind of Chinese medicine composition for treating diabetes |
| CN110420265A (en) * | 2019-09-04 | 2019-11-08 | 甘肃皇汉医学研究院有限公司 | A kind of method for production of Chinese medicine preparation and its Chinese patent drug for treating diabetes |
| CN116440236A (en) * | 2023-05-23 | 2023-07-18 | 甘肃中医药大学 | Pharmaceutical composition for treating diabetes |
-
2011
- 2011-03-16 CN CN2011100628125A patent/CN102091177A/en active Pending
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102526332A (en) * | 2012-02-07 | 2012-07-04 | 广西圣特药业有限公司 | Medicine for treating diabetes and preparation method thereof |
| CN103083461A (en) * | 2012-12-06 | 2013-05-08 | 宁夏易欣回药科技有限公司 | Medicine composition for treating diabetes |
| CN103989988A (en) * | 2014-04-22 | 2014-08-20 | 安徽省太湖山中药饮片有限公司 | Traditional Chinese medicine composition for assisting diabetes treatment |
| CN107582859A (en) * | 2017-10-25 | 2018-01-16 | 陆惠红 | A kind of Chinese medicine for treating diabetes |
| CN108096468A (en) * | 2017-12-15 | 2018-06-01 | 佛山市米良仓科技有限公司 | A kind of Chinese medicine composition for treating diabetes |
| CN110420265A (en) * | 2019-09-04 | 2019-11-08 | 甘肃皇汉医学研究院有限公司 | A kind of method for production of Chinese medicine preparation and its Chinese patent drug for treating diabetes |
| CN110420265B (en) * | 2019-09-04 | 2021-07-30 | 甘肃皇汉医学研究院有限公司 | A Chinese medicinal composition for treating diabetes, and its preparation method |
| CN116440236A (en) * | 2023-05-23 | 2023-07-18 | 甘肃中医药大学 | Pharmaceutical composition for treating diabetes |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102091177A (en) | Traditional Chinese medicine health product for adjuvant therapy of diabetes | |
| CN101274042A (en) | Medicament composition for curing hyperlipemia and method of preparing the same | |
| CN101843694B (en) | Chinese medicament for treating chronic hepatitis | |
| CN102048899A (en) | Traditional Chinese medicine preparation for treating impotence | |
| CN102389480A (en) | Chinese medicament for treating hepatitis | |
| CN102379989A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN102327358A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN102379947A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN105250427A (en) | Pharmaceutical composition for treating heart diseases | |
| CN101843828A (en) | Chinese medicament for treating climacteric syndromes | |
| CN102389479A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN101843740B (en) | Chinese medicament for treating climacteric syndromes | |
| CN102172375A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN101953925A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN101843829B (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101537121B (en) | Chinese medicine for treating arteriosclerosis | |
| CN101850046B (en) | Chinese medicament for treating chronic hepatitis | |
| CN101843693A (en) | Chinese medicament for treating diabetic nephropathy | |
| CN102379994A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN101843707B (en) | Chinese medicament for treating chronic hepatitis | |
| CN101843726B (en) | Chinese medicament for treating chronic hepatitis | |
| CN101843825B (en) | Chinese medicament for treating climacteric syndromes | |
| CN101357221A (en) | Traditional Chinese medicine preparation for treating female coldness | |
| CN101843817B (en) | Chinese medicament for treating chronic hepatitis | |
| CN101874870B (en) | Traditional Chinese medicine for treating chronic hepatitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20110615 |